SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Cheng, J-S
Right arrow Articles by Jan, C-R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheng, J-S
Right arrow Articles by Jan, C-R
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Effects of the antianginal drug fendiline on Ca2+ movement in hepatoma cells

J-S Cheng

Department of Medicine, School of Medicine, National Yang Ming University, Taipei, Taiwan

J-L Wang

Department of Rehabilitation, School of Medicine, National Yang Ming University, Taipei, Taiwan

Y-K Lo

K-J Chou

K-C Lee

C-P Liu

Department of Medicine, School of Medicine, National Yang Ming University, Taipei, Taiwan

H-T Chang

Department of Surgery, School of Medicine, National Yang Ming University, Taipei, Taiwan

C-R Jan

Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; Department of Biology and Institute of Life Sciences, National Sun Yat Sen University, Kaohsiung, Taiwan; Department of Medical Education and Research, Kaohsiung Veterans General Hospital, 386 Ta Chung 1st Road, Kaohsiung 813, Taiwan

This study investigated the effect of the anti-anginal drug, fendiline, on intracellular free Ca2+ levels ([Ca2+]i)inHA/ 22 human hepatoma cells by using fura-2 as a fluorescent Ca2+ dye. Fendiline (1-100 µM) increased [Ca2+]i with an EC50 of 25 µM. Removal of extracellular Ca2+ reduced the [Ca2+]i signals by 51-5%. Fendiline (10 µM)-induced Ca2+release was abolished by pretreatment with 1 µM thapsigargin (an endoplasmic reticulum Ca2+ pump inhibitor). Inhibition of phospholipase C with 2 µM 1-(6-((17ß 3 methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H pyrrole-2,5-dione (U73122) did not alter 10 µM fendilineinducedCa2+ release.Severalothercalmodulinantagonists, such as phenoxybenzamine (100-200 µM), trifluoperazine (5-50 µM),andfluphenazine N-chloroethane(2-100 µM), hadno effect on[Ca2+]i. Together, it wasfound that fendiline increased [Ca2+]i in human hepatoma cells by discharging Ca2+ from the endoplasmic reticulum in an inositol 1,4,5 trisphosphate-independent manner and by inducing Ca2+entry. This effect of fendiline does not appear to be via antagonism of calmodulin.

Key Words: Ca2+ signaling • fendiline • fura-2 • hepatoma cells • Ca2+stores

Human & Experimental Toxicology, Vol. 20, No. 7, 359-364 (2001)
DOI: 10.1191/096032701680350523


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




Advertisement